vortioxetine hydrobromide and its Impurities

Vortioxetine Hydrobromide is used as a treatment for major depressive disorder. It is sold under the trade names Trintellix. It is taken by mouth.Reference standards of Vortioxetine Hydrobromide API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 20 results for vortioxetine hydrobromide Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 22 21000

Vortioxetine Hydrobromide

Vortioxetine Hydrobromide


  • Catalogue No.:PA 22 21000

  • CAS :

    960203-27-4

  • Molecular Formula : C18H23BrN2S

  • Molecular Weight : 379.36

Drug Reference Standards & Impurity Synthesis in India
PA 22 21510

Vortioxetine Sulfoxide

Vortioxetine Sulfoxide


  • Catalogue No.:PA 22 21510

  • CAS :

    1429908-35-9

  • Molecular Formula : C18H22N2OS

  • Molecular Weight : 314.45

Drug Reference Standards & Impurity Synthesis in India
PA 22 21520

1,2-Bis(2,4-dimethylphenyl)disulfane

1,2-Bis(2,4-dimethylphenyl)disulfane


  • Catalogue No.:PA 22 21520

  • CAS :

    13616-83-6

  • Molecular Formula : C16H18S2

  • Molecular Weight : 274.44

Drug Reference Standards & Impurity Synthesis in India
PA 22 21550

(3,5-Dimethylphenyl)(2-nitrophenyl)sulfane

(3,5-Dimethylphenyl)(2-nitrophenyl)sulfane


  • Catalogue No.:PA 22 21550

  • CAS :

    640767-43-7

  • Molecular Formula : C14H13NO2S

  • Molecular Weight : 259.32

Drug Reference Standards & Impurity Synthesis in India
PA 22 21560

2-((3,5-Dimethylphenyl)thio)aniline

2-((3,5-Dimethylphenyl)thio)aniline


  • Catalogue No.:PA 22 21560

  • CAS :

    640767-44-8

  • Molecular Formula : C14H15NS

  • Molecular Weight : 229.34

Drug Reference Standards & Impurity Synthesis in India
PA 22 21570

1-(2-((3,5-Dimethylphenyl)thio)phenyl)piperazine

1-(2-((3,5-Dimethylphenyl)thio)phenyl)piperazine


  • Catalogue No.:PA 22 21570

  • CAS :

    508233-75-8

  • Molecular Formula : C18H22N2S

  • Molecular Weight : 298.45

Drug Reference Standards & Impurity Synthesis in India
PA 22 21580

Bis(2-(4-(2-((2,4-dimethylphenyl)thio)phenyl)piperazin-1-yl)ethyl)amine

Bis(2-(4-(2-((2,4-dimethylphenyl)thio)phenyl)piperazin-1-yl)ethyl)amine


  • Catalogue No.:PA 22 21580

  • CAS :

    NA

  • Molecular Formula : C40H51N5S2

  • Molecular Weight : 666

Drug Reference Standards & Impurity Synthesis in India
PA 22 21590

N1-(2-Chloroethyl)-N2-(2-((2,4-dimethylphenyl)thio)phenyl)ethane-1,2-diamine

N1-(2-Chloroethyl)-N2-(2-((2,4-dimethylphenyl)thio)phenyl)ethane-1,2-diamine


  • Catalogue No.:PA 22 21590

  • CAS :

    1928741-88-1

  • Molecular Formula : C18H23ClN2S

  • Molecular Weight : 334.91

Drug Reference Standards & Impurity Synthesis in India
PA 22 21600

N-formyl Vortioxetine

N-formyl Vortioxetine


  • Catalogue No.:PA 22 21600

  • CAS :

    2135576-73-5

  • Molecular Formula : C19H22N2OS

  • Molecular Weight : 326.46

Drug Reference Standards & Impurity Synthesis in India
PA 22 21610

N-Methyl Vortioxetine Hydrobromide

N-Methyl Vortioxetine Hydrobromide


  • Catalogue No.:PA 22 21610

  • CAS :

    NA

  • Molecular Formula : C19H25BrN2S

  • Molecular Weight : 393.39

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211000

1-(2-((2,6-Dimethylphenyl)thio)phenyl)piperazine Hydrobromide

1-(2-((2,6-Dimethylphenyl)thio)phenyl)piperazine Hydrobromide


  • Catalogue No.:PA 22 0211000

  • CAS :

    3070439-18-5

  • Molecular Formula : C18H23BrN2S

  • Molecular Weight : 379.36

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211001

1-(2-((2,5-Dimethylphenyl)thio)phenyl)piperazine Hydrobromide

1-(2-((2,5-Dimethylphenyl)thio)phenyl)piperazine Hydrobromide


  • Catalogue No.:PA 22 0211001

  • CAS :

    NA

  • Molecular Formula : C18H23BrN2S

  • Molecular Weight : 379.36

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211002

(2,4-Dimethylphenyl)(2-nitrophenyl)sulfane

(2,4-Dimethylphenyl)(2-nitrophenyl)sulfane


  • Catalogue No.:PA 22 0211002

  • CAS :

    1610527-49-5

  • Molecular Formula : C14H13NO2S

  • Molecular Weight : 259.32

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211003

2-[(2,4-Dimethylphenyl)sulfanyl]aniline

2-[(2,4-Dimethylphenyl)sulfanyl]aniline


  • Catalogue No.:PA 22 0211003

  • CAS :

    1019453-85-0

  • Molecular Formula : C14H15NS

  • Molecular Weight : 229.34

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211004

1-{4-[(2,4-Dimethylphenyl)sulfanyl]phenyl}piperazine

1-{4-[(2,4-Dimethylphenyl)sulfanyl]phenyl}piperazine


  • Catalogue No.:PA 22 0211004

  • CAS :

    1815608-51-5

  • Molecular Formula : C18H22N2S

  • Molecular Weight : 298.45

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211005

3-Bromo-vortioxetine Hydrobromide

3-Bromo-vortioxetine Hydrobromide


  • Catalogue No.:PA 22 0211005

  • CAS :

    2725536-51-4

  • Molecular Formula : C18H22Br2N2S

  • Molecular Weight : 458.26

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211006

Vortioxetine 1,4-Vortioxetine Isomer

Vortioxetine 1,4-Vortioxetine Isomer


  • Catalogue No.:PA 22 0211006

  • CAS :

    NA

  • Molecular Formula : C18H23BrN2S

  • Molecular Weight : 379.36

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211007

Vortioxetine Sulfone

Vortioxetine Sulfone


  • Catalogue No.:PA 22 0211007

  • CAS :

    1639263-80-1

  • Molecular Formula : C18H22N2O2S

  • Molecular Weight : 330.45

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211008

1-(2-((3,5-Dimethylphenyl)thio)phenyl)piperazine Hydrobromide Hydrate

1-(2-((3,5-Dimethylphenyl)thio)phenyl)piperazine Hydrobromide Hydrate


  • Catalogue No.:PA 22 0211008

  • CAS :

    NA

  • Molecular Formula : C18H25BrN2OS

  • Molecular Weight : 397.38

Drug Reference Standards & Impurity Synthesis in India
PA 22 0211009

1-(2-((3,5-Dimethylphenyl)thio)phenyl)piperazine Hydrobromide

1-(2-((3,5-Dimethylphenyl)thio)phenyl)piperazine Hydrobromide


  • Catalogue No.:PA 22 0211009

  • CAS :

    3070439-20-9

  • Molecular Formula : C18H23BrN2S

  • Molecular Weight : 379.36

pharmaffiliates